Global Anticoagulant Market 2017-2021

Published: Feb 2017 Pages: 79 SKU: IRTNTR12016

Overview of the global anticoagulant market

Technavio’s market research analyst predicts the global anticoagulant market to grow steadily at a CAGR of above 7% by 2021. One of the primary drivers for this market is the rise in demand for novel oral anticoagulants (NOACs). NOACs target either thrombin or factor Xa to prevent and treat thrombosis. They show quick action and do not require continuous monitoring. They also have better safety and efficacy profiles when compared with conventional therapies such as warfarin. Moreover, the introduction of anticoagulant antidotes in 2015 such as idarucizumab into the market is expected to increase the acceptance of NOACs, as the risk of bleeding will be eradicated. Consequently, this will propel the growth of the global anticoagulant market during the forecast period.

In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market for the next few years. The Americas market is growing at a significant growth pace with the introduction of NOACs. The warfarin showed high growth when compared with the oral anticoagulant. However, the revenue generated from the sales of warfarin is low due to the availability of generics, which are available at significantly lower prices. With vitamin K antagonists taking over the share of factor Xa inhibitors and DTIs, the Americas is expected to dominate to global anticoagulant market for the coming few years.

Competitive landscape and key vendors

The global anticoagulant market is highly competitive due to the presence of several international and regional vendors. The market has observed a high growth because of the increase in usage of NOACs and the growing number of surgeries worldwide. This has influx intense competition among the players in the NOACs market, which is emerging in the anticoagulant market. Also, the growing focus of established vendors in the emerging economies will likely change the market dynamics in the next four years.

Leading vendors in the market are –

  • Bayer HealthCare
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Daiichi Sankyo
  • Johnson & Johnson
  • Sanofi

Other prominent vendors in the anticoagulant market include AstraZeneca, Eli Lilly, Keryx Biopharmaceuticals, LEO Pharma, Pfizer, and The Medicines Company.

Segmentation by ROA and analysis of the anticoagulant market

  • Oral
  • Injectable

During 2016, the oral anticoagulant drugs dominated the anticoagulant market and accounted for a major part of the overall market share. Factors such as high patience adherence, cost-effectiveness, and painless treatment are the key contributors to the dominance of this segment in the global market.

Segmentation by drug class and analysis of the anticoagulant market

  • Factor Xa inhibitors
  • DTIs
  • Heparin
  • Vitamin K antagonists

In this market study, analysts have estimated factor Xa inhibitors segment to dominate the anticoagulant market during the forecast period. With major drug approvals, such as rivaroxaban (XARELTO), edoxaban (SAVAYSA), and apixiban (ELIQUIS) the factor Xa inhibitors are expected to grow its market share in the next four years.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2021?
  • What are the key factors driving the global anticoagulant market?
  • What are the key market trends impacting the growth of the global anticoagulant market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global anticoagulant market?
  • What are the market opportunities and threats faced by the vendors in the global anticoagulant market?
  • Trending factors influencing the market shares of the Americas, APAC, and EMEA.
  • What are the key outcomes of the five forces analysis of the global anticoagulant market?

Technavio also offers customization on reports based on specific client requirement.

Related reports

Table of Contents

PART 01: Executive summary 

PART 02: Scope of the report 

  • Market overview 
  • Top-vendor offerings 

PART 03: Market research methodology 

  • Research methodology 
  • Economic indicators 

PART 04: Introduction 

  • Key market highlights 

PART 05: Disease overview 

PART 06: Pipeline analysis 

PART 07: Market landscape 

  • Market overview 
  • Five forces analysis 

PART 08: Market segmentation by ROA 

  • Oral anticoagulants 
  • Injectable anticoagulants 
  • PART 09: Market segmentation by drug class 
  • Factor Xa inhibitors 
  • DTIs 
  • Heparin 
  • Vitamin K antagonists 

PART 10: Market segmentation by application 

  • DVT 
  • PE 
  • AF 
  • Others 

PART 11: Geographical segmentation 

  • Global anticoagulant market in Americas 
  • Anticoagulant market in EMEA 
  • Anticoagulant market in APAC 

PART 12: Market drivers 

  • Increasing demand for NOACs 
  • Growing prevalence of coagulation disorders 
  • Increase in hip and knee surgeries 

PART 13: Impact of drivers 

PART 14: Market challenges 

  • Increasing cost of NOACs 
  • Lack of antidotes in the market for NOACs 
  • Patent expiry: a threat to market 

PART 15: Impact of drivers and challenges 

PART 16: Market trends 

  • Strategic alliance 
  • Increasing focus toward emerging economies 
  • Patient assistance programs 

PART 17: Vendor landscape 

  • Competitive scenario 
  • Other prominent vendors 

PART 18: Key vendor analysis 

  • Bayer HealthCare 
  • Boehringer Ingelheim 
  • Bristol-Myers Squibb 
  • Daiichi Sankyo 
  • Johnson & Johnson 
  • Sanofi 

PART 19: Appendix 

  • List of abbreviations 

PART 20: Explore Technavio 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

PURCHASE FULL REPORT OF

market

QUICK BUY

Key Questions Answered

  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis